Bd announces 510(k) clearance of expanded indications for the rotarex™ atherectomy system

Franklin lakes, n.j., oct. 6, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it has received 510(k) clearance for expanded indications from the u.s. food and drug administration (fda) for the rotarex™ atherectomy system.
BDX Ratings Summary
BDX Quant Ranking